Empower
Hereditary cancer testing, made accessible
Empower is a genetic test for those who want to know more about their risk for developing cancer or why it might be common in their family.
Hereditary cancer risk assessment
Blood, Saliva
2-3 weeks
Learn More about Hereditary Cancer Risk with Empower
1
Provider orders an Empower Hereditary Cancer Test.
2
Patient provides a blood or saliva sample.
3
Patient reviews results with their provider within 2-3 weeks.
Streamlined family cancer history intake with NEVA
-
Patients can use pre-appointment time to answer health history questions
-
You have a single view of patient risk assessment details and all Natera test orders
Actionable reports to guide next steps
-
Screenings that detect cancer at its earliest, most treatable stage
-
Risk-reducing medications and surgeries
-
Surgical or therapeutic decisions for patients diagnosed with cancer
-
Informing family members to help them proactively manage hereditary cancer risk
Patients could meet guidelines for hereditary cancer testing1
1 in 4
Percent of all cancers believed to be caused by inherited mutations2
5-10%
Women who will be affected by breast cancer in their lifetime3
1 in 8
Inherited mutations can significantly increase lifetime risk for developing cancer4
References
- Genetic Testing for Inherited Cancer Susceptibility Syndromes, National Cancer Institute. March 2019. Available here.
- American Cancer Society. How Common Is Breast Cancer? Jan. 2020. Available here:
- National Cancer Institute. SEER Cancer Stat Facts: Prostate Cancer. Accessed here on March 15, 2019. Available here
- Cancer risk estimates for a positive result are typically based on individuals with a family or personal history of cancer. NCCN Clinical Practice Guidelines in Oncology Genetic/Familial High Risk Assessment: Breast, Ovarian and Pancreatic v1.2020